PULMONARY EDEMA IN INFLUENZAL PNEUMONIA OF THE MOUSE AND THE RELATION OF FLUID IN THE LUNG TO THE INCEPTION OF PNEUMOCOCCAL PNEUMONIA
- PMID: 19871702
- PMCID: PMC2135962
- DOI: 10.1084/jem.91.3.245
PULMONARY EDEMA IN INFLUENZAL PNEUMONIA OF THE MOUSE AND THE RELATION OF FLUID IN THE LUNG TO THE INCEPTION OF PNEUMOCOCCAL PNEUMONIA
Abstract
Pulmonary edema is a component of the fully developed influenza viral lesion in the mouse. Mice with experimental pulmonary fluid have an increased susceptibility to inhaled pneumococci and under these circumstances the organisms grow in the lung and produce the lesion of bacterial pneumonia. The presence of pulmonary edema in the lesion due to the influenza virus in the lung of the mouse appears to account adequately for the previous observation that inhaled pneumococci grow in the influenza viral lesion. Mice dying of pneumococcal septicemia after inhaling fine droplets containing this organism do not have pneumonia. The delay in migration of polymorphonuclear leucocytes into the lung after injection of pneumococci suspended in serum is an important factor in susceptibility to infection since it allows ample time for pneumococci to grow in the pulmonary fluid. The slow phagocytic action of pulmonary macrophages likewise permits growth of pneumococci. Conditions in human beings that are known to be complicated by pulmonary edema are also known to be associated with increased susceptibility to secondary bacterial pneumonia.
Similar articles
-
STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.J Exp Med. 1941 Jan 31;73(2):201-22. doi: 10.1084/jem.73.2.201. J Exp Med. 1941. PMID: 19871073 Free PMC article.
-
Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci.J Exp Med. 1949 Jan;89(1):53-68. doi: 10.1084/jem.89.1.53. J Exp Med. 1949. PMID: 18099165 Free PMC article.
-
STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.J Exp Med. 1946 Sep 30;84(4):365-76. doi: 10.1084/jem.84.4.365. J Exp Med. 1946. PMID: 19871575 Free PMC article.
-
Influenza pneumonia.Semin Respir Infect. 1987 Jun;2(2):122-9. Semin Respir Infect. 1987. PMID: 3321270 Review.
-
The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.Dan Med Bull. 2000 Nov;47(5):313-27. Dan Med Bull. 2000. PMID: 11155659 Review.
Cited by
-
Reducing the impact of influenza-associated secondary pneumococcal infections.Immunol Cell Biol. 2016 Jan;94(1):101-8. doi: 10.1038/icb.2015.71. Epub 2015 Jul 21. Immunol Cell Biol. 2016. PMID: 26134269
-
Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.J Infect Dis. 2017 Feb 15;215(suppl_1):S58-S63. doi: 10.1093/infdis/jiw466. J Infect Dis. 2017. PMID: 28375519 Free PMC article.
-
Experimental combined viral and bacterial infection (influenza C and hemophilus influenzae, type B) in embryonated eggs.J Exp Med. 1956 Dec 1;104(6):947-58. doi: 10.1084/jem.104.6.947. J Exp Med. 1956. PMID: 13376814 Free PMC article.
-
A mathematical model of intrahost pneumococcal pneumonia infection dynamics in murine strains.J Theor Biol. 2014 Jul 21;353:44-54. doi: 10.1016/j.jtbi.2014.02.021. Epub 2014 Mar 2. J Theor Biol. 2014. PMID: 24594373 Free PMC article.
-
Angiopoietin-like 4 Increases Pulmonary Tissue Leakiness and Damage during Influenza Pneumonia.Cell Rep. 2015 Feb 10;10(5):654-663. doi: 10.1016/j.celrep.2015.01.011. Epub 2015 Feb 5. Cell Rep. 2015. PMID: 25660016 Free PMC article.